Trasplante pulmonar ex vivo . Primera experiencia en Chile y Latinoamérica
Background: The number of patients waiting for a lung transplant worldwide greatly exceeds the number of available donors. Ex vivo lung perfusion is a useful tool that allows marginal donor lungs to be evaluated and reconditioned for a successful lung transplantation. Aim: To describe the first Ch...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2021
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000200171 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872021000200171 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720210002001712021-06-25Trasplante pulmonar ex vivo . Primera experiencia en Chile y LatinoaméricaUndurraga M.,FelipeVega S.,JavierFajardo J.,ChristianDíaz G.,RodrigoLazo P.,DavidRodríguez G.,HuascarVillalabeitia R.,EliSepúlveda V.,EdgardoRufs B.,JorgeDreyse D.,JorgeAlarcón O.,FelipeValenzuela S.,JosefaSeguel G.,NataliaCastillo R.,RobertoArrau P.,LorenaCalabrán R.,LorenaRodríguez D.,PatricioYeung,Jonathan C. Latin America Lung Lung Transplantation Perfusion Background: The number of patients waiting for a lung transplant worldwide greatly exceeds the number of available donors. Ex vivo lung perfusion is a useful tool that allows marginal donor lungs to be evaluated and reconditioned for a successful lung transplantation. Aim: To describe the first Chilean and Latin American experience in ex vivo lung perfusion for marginal donor lungs before transplantation. Material and Methods: Descriptive analysis of all ex vivo lung perfusion conducted for marginal donor lungs at a private clinic, from April 2019 to October 2020. High risk donor lungs and rejected lungs from other transplantation centers were included. The “Toronto Protocol” was used for ex vivo lung perfusion. Donor lung characteristics and recipient outcomes were studied. Results: During the study period, five ex vivo lung perfusions were performed. All lungs were reconditioned and transplanted. No complications were associated. There were no primary graft dysfunctions and only one chronic allograft dysfunction. There was no mortality during the first year. The median arterial oxygen partial pressure/fractional inspired oxygen ratio increased from 266 mm Hg in the donor lung to 419 after 3 hours of ex vivo lung perfusion (p = 0.043). Conclusions: ex vivo lung perfusion is a safe and useful tool that allows marginal donor lungs to be reconditioned and successfully transplanted.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.149 n.2 20212021-02-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000200171es10.4067/s0034-98872021000200171 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Latin America Lung Lung Transplantation Perfusion |
spellingShingle |
Latin America Lung Lung Transplantation Perfusion Undurraga M.,Felipe Vega S.,Javier Fajardo J.,Christian Díaz G.,Rodrigo Lazo P.,David Rodríguez G.,Huascar Villalabeitia R.,Eli Sepúlveda V.,Edgardo Rufs B.,Jorge Dreyse D.,Jorge Alarcón O.,Felipe Valenzuela S.,Josefa Seguel G.,Natalia Castillo R.,Roberto Arrau P.,Lorena Calabrán R.,Lorena Rodríguez D.,Patricio Yeung,Jonathan C. Trasplante pulmonar ex vivo . Primera experiencia en Chile y Latinoamérica |
description |
Background: The number of patients waiting for a lung transplant worldwide greatly exceeds the number of available donors. Ex vivo lung perfusion is a useful tool that allows marginal donor lungs to be evaluated and reconditioned for a successful lung transplantation. Aim: To describe the first Chilean and Latin American experience in ex vivo lung perfusion for marginal donor lungs before transplantation. Material and Methods: Descriptive analysis of all ex vivo lung perfusion conducted for marginal donor lungs at a private clinic, from April 2019 to October 2020. High risk donor lungs and rejected lungs from other transplantation centers were included. The “Toronto Protocol” was used for ex vivo lung perfusion. Donor lung characteristics and recipient outcomes were studied. Results: During the study period, five ex vivo lung perfusions were performed. All lungs were reconditioned and transplanted. No complications were associated. There were no primary graft dysfunctions and only one chronic allograft dysfunction. There was no mortality during the first year. The median arterial oxygen partial pressure/fractional inspired oxygen ratio increased from 266 mm Hg in the donor lung to 419 after 3 hours of ex vivo lung perfusion (p = 0.043). Conclusions: ex vivo lung perfusion is a safe and useful tool that allows marginal donor lungs to be reconditioned and successfully transplanted. |
author |
Undurraga M.,Felipe Vega S.,Javier Fajardo J.,Christian Díaz G.,Rodrigo Lazo P.,David Rodríguez G.,Huascar Villalabeitia R.,Eli Sepúlveda V.,Edgardo Rufs B.,Jorge Dreyse D.,Jorge Alarcón O.,Felipe Valenzuela S.,Josefa Seguel G.,Natalia Castillo R.,Roberto Arrau P.,Lorena Calabrán R.,Lorena Rodríguez D.,Patricio Yeung,Jonathan C. |
author_facet |
Undurraga M.,Felipe Vega S.,Javier Fajardo J.,Christian Díaz G.,Rodrigo Lazo P.,David Rodríguez G.,Huascar Villalabeitia R.,Eli Sepúlveda V.,Edgardo Rufs B.,Jorge Dreyse D.,Jorge Alarcón O.,Felipe Valenzuela S.,Josefa Seguel G.,Natalia Castillo R.,Roberto Arrau P.,Lorena Calabrán R.,Lorena Rodríguez D.,Patricio Yeung,Jonathan C. |
author_sort |
Undurraga M.,Felipe |
title |
Trasplante pulmonar ex vivo . Primera experiencia en Chile y Latinoamérica |
title_short |
Trasplante pulmonar ex vivo . Primera experiencia en Chile y Latinoamérica |
title_full |
Trasplante pulmonar ex vivo . Primera experiencia en Chile y Latinoamérica |
title_fullStr |
Trasplante pulmonar ex vivo . Primera experiencia en Chile y Latinoamérica |
title_full_unstemmed |
Trasplante pulmonar ex vivo . Primera experiencia en Chile y Latinoamérica |
title_sort |
trasplante pulmonar ex vivo . primera experiencia en chile y latinoamérica |
publisher |
Sociedad Médica de Santiago |
publishDate |
2021 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000200171 |
work_keys_str_mv |
AT undurragamfelipe trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT vegasjavier trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT fajardojchristian trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT diazgrodrigo trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT lazopdavid trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT rodriguezghuascar trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT villalabeitiareli trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT sepulvedavedgardo trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT rufsbjorge trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT dreysedjorge trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT alarconofelipe trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT valenzuelasjosefa trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT seguelgnatalia trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT castillorroberto trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT arrauplorena trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT calabranrlorena trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT rodriguezdpatricio trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica AT yeungjonathanc trasplantepulmonarexvivoprimeraexperienciaenchileylatinoamerica |
_version_ |
1718437182167842816 |